Antithrombotics Flashcards
Primary hemostasis steps
Platelet shape change and activation
Platelet adhesion
Platelet aggregation
Secondary hemostasis step
Activation of intrinsic/extrinsic coagulation cascades
ADP activates platelets through a G_ protein coupled receptor
Gi
Anti platelet drugs
Aspirin
Clopidogrel
Abciximab
Vorapaxar
Thrombolytic drug
T-PA
Vitamin K antagonist
Warfarin
ADP receptor antagonist
Clopidogrel
Clopidogrel MOA
Prodrug metabolized in liver
Blocks platelet aggregation by binding irreversibly to P2Y12 ADP receptors
Clinical uses of clopidogrel
Reduce rate of stroke, MI, atherosclerosis
Similar but slightly.,more effective than aspirin
Black box warning for clopidogrel
Therapeutic failure in patients with loss of CYP2C19*2 allele
(Need to be tested for allele before starting drug)
Adverse effects of Clopidogrel
Bleeding
GI upset
Thrombotic thrombocytic purpura
Drug interactions with Clopidogrel
NSAIDs
omeprazole
Abciximab MOA
GPIIb/IIIa antagonist
Blocks platelet aggregation/fibrinogen binding
Clinical use of abciximab
Most effective anti platelet drug (very expensive)
Short term to prevent ischemic events
Vorapaxar MOA
Blocks PAR-1 receptor
Vorapaxar clinical use
Reduce thrombosis post-MI
How long does Vorapaxar effect last?
Up to 4 weeks
Boxed warning of vorapaxar
Bleeding (intracranial hemorrhage)